[In Process Citation].

No abstract is available for this paper.

• Publication year

  2015

• Venue

  MMW, Fortschritte der Medizin

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s15006-015-3162-7PMID 26048116
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hodgkin lymphoma is as common as non‐Hodgkin lymphoma in HIV‐positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study

  2015cited by this paper
• Therapy of HIV-associated lymphoma—recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG)

  2014cited by this paper
• Causes of death in HIV-infected patients from the Cologne–Bonn cohort

  2014cited by this paper
• Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.

  2013cited by this paper
• Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.

  2012cited by this paper
• Role of serum free light chains in predicting HIV‐associated non‐Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

  2012cited by this paper
• Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients

  2012cited by this paper
• B-Cell Stimulatory Cytokines and Markers of Immune Activation Are Elevated Several Years Prior to the Diagnosis of Systemic AIDS–Associated Non-Hodgkin B-Cell Lymphoma

  2011cited by this paper
• Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.

  2009cited by this paper
• Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

  2005cited by this paper

• No citing papers are available for this paper.